University of California

Biogen appoints Anirvan Ghosh SVP, Research and Early Development

Friday, March 17, 2017

Biogen appointed Anirvan Ghosh, Ph.D., as senior vice president, Research and Early Development (RED). Dr. Ghosh will lead Biogen’s RED organization in the discovery and development of drug candidates from idea through proof of concept. He will report to Michael Ehlers, M.D., Ph.D., executive vice president, Head of Research and Development. Dr. Ghosh will begin his service at Biogen in April.

[Read More]

CRISPR, Intellia, Caribou and ERS Genomics provide update on CRISPR/Cas9 U.S. patent

Friday, February 17, 2017

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics provided an update on the Patent Trial & Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) decision on the motions filed by the University of California, the University of Vienna and Dr. Emmanuelle Charpentier (collectively, UC), on one hand, and the Broad Institute, Harvard University and the Massachusetts Institute of Technology (collectively, Broad), on the other, in the interference proceeding relating to CRISPR/Cas9 genome editing technology.

[Read More]

Chan Zuckerberg Biohub names first cohort of engineers, scientists and technologists

Wednesday, February 8, 2017

The Chan Zuckerberg Biohub (CZ Biohub) has announced its first cohort of 47 CZ Biohub Investigators from the faculty of the University of California, Berkeley, Stanford University and the University of California, San Francisco. This group includes both highly accomplished senior professors as well as up-and-coming young faculty. Each of the CZ Biohub Investigators will receive a five-year appointment and up to $1.5 million in funding to conduct life science research in their respective areas of expertise.

[Read More]

Illumina hires Garret Hampton to head Clinical Genomics Unit

Tuesday, January 3, 2017

Illumina, continuing its strategy to bring the power of genomics into clinical applications, has named one of the world’s top clinical genomics experts to head its clinical genomics unit. Garret Hampton, Ph.D., will join as executive vice president of Clinical Genomics for the company, starting January 9, 2017.

[Read More]

NIH funds additional medical centers for precision medicine research program

Monday, October 17, 2016

The NIH has announced awards to add four regional medical center groups to the national network of healthcare provider organizations (HPOs) that will implement the Precision Medicine Initiative (PMI) Cohort Program. Combined, the new HPOs will receive initial funds of $5.5 million to begin recruitment and build infrastructure. As efforts advance, the centers may receive first-year funds up to a total of $16 million. The four HPOs join awardees announced earlier this year, to enroll interested individuals, gather participants’ health information and biospecimens and provide input on developing plans for the program.

[Read More]

NIH funds research network focused on HIV-infected youth

Monday, September 26, 2016

The NIH has awarded funding for a research network devoted to the health and well-being of adolescents and young adults with HIV or at risk for HIV infection. The awards, up to $24 million in 2016, provide for three research centers and a data coordinating center that will make up the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN).

[Read More]

UnDx Consortium to focus on precision medicine

Tuesday, August 16, 2016

UnDx Consortium has launched. This organization brings together five precision medicine technology providers and experts from medical centers and universities across the country to collaborate in an effort to produce new hypotheses for a set of six patients struggling with undiagnosed diseases. UnDx Consortium will explore results of cutting-edge tests analyzing samples from these patients and their families.

[Read More]